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Abstract
Introduction Few studies have investigated the influence
of storage conditions on urine samples and none of them
used targeted mass spectrometry (MS).
Objectives We investigated the stability of metabolite
profiles in urine samples under different storage conditions
using targeted metabolomics.
Methods Pooled, fasting urine samples were collected and
stored at -80 C (biobank standard), -20 C (freezer),
4 C (fridge), *9 C (cool pack), and *20 C (room
temperature) for 0, 2, 8 and 24 h. Metabolite concentra-
tions were quantified with MS using the AbsoluteIDQTM
p150 assay. We used the Welch-Satterthwaite-test to
compare the concentrations of each metabolite. Mixed
effects linear regression was used to assess the influence of
the interaction of storage time and temperature.
Results The concentrations of 63 investigated metabolites
were stable at -20 and 4 C for up to 24 h when compared
to samples immediately stored at -80 C. When stored at
*9 C for 24 h, few amino acids (Arg, Val and Leu/Ile)
significantly decreased by 40% in concentration
(P\ 7.9E-04); for an additional three metabolites (Ser,
Met, Hexose H1) when stored at *20 C reduced up to
60% in concentrations. The concentrations of four more
metabolites (Glu, Phe, Pro, and Thr) were found to be
significantly influenced when considering the interaction
between exposure time and temperature.
Conclusion Our findings indicate that 78% of quantified
metabolites were stable for all examined storage condi-
tions. Particularly, some amino acid concentrations were
sensitive to changes after prolonged storage at room tem-
perature. Shipping or storing urine samples on cool packs
or at room temperature for more than 8 h and multiple
numbers of freeze and thaw cycles should be avoided.
Keywords Urine  Storage conditions  Targeted
metabolomics  Pre-analytics  Amino acids
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1 Introduction
The field of metabolomics has garnered much attention in
recent years (Beger et al. 2016; Bouatra et al. 2013).
Potential biomarkers for diseases such as type 2 diabetes and
metabolite signatures ofmedication use and lifestyle choices
(e.g. smoking) have been identified (Adam et al. 2016;
Brandmaier et al. 2015; Wang-Sattler et al. 2012; Xu et al.
2013, 2015). Identified metabolites provide insight into key
physiological mechanisms and underlying pathways.
Extensive research on the influence of storage condi-
tions on human plasma and serum metabolite profiles has
been conducted (Breier et al. 2014; Anton et al. 2015). A
recent study found that serum concentration of 24 out of
127 quantified metabolites significantly changed at room
temperature when compared to the values samples stored at
-80 C (Anton et al. 2015). Regarding plasma, the con-
centration of 44 out of 159 metabolites changed signifi-
cantly when kept for 24 h at room temperature (Breier
et al. 2014).
With respect to its noninvasiveness, metabolomics of
urine samples has become a major focus. The collection of
such samples can be conducted without supervision of
medical experts (Gao 2013). On the other hand, this means
that the samples are not necessarily taken under a con-
trolled, well-regulated clinical environment that enhances
measurement reproducibility. Therefore, it is pivotal to
determine the effects of pre-analytical sample handling,
including storage conditions. Previous research on the pre-
analytical effects on human urine samples was regarding
non-targeted mass spectrometry (MS) or nuclear magnetic
resonance (NMR) technology (Barton et al. 2008; Bernini
et al. 2011; Budde et al. 2016; Emwas et al. 2015; Gika
et al. 2008; Lauridsen et al. 2007; Roux et al. 2015).
In our study, we use a targeted MS approach to inves-
tigate the effects of storage conditions, as well as the
interaction of storage time and temperature, on urine
metabolite concentrations. The urine samples were stored
for 2, 8, and 24 h at temperatures ranging from -80
to *20 C and exposed to up to three freeze–thaw cycles.
2 Materials and methods
2.1 Urine sample preparation under different
storage conditions
Urine was collected from six healthy female volunteers
between 8:00 and 8:45 am after overnight fasting in sterile
disposable containers. To lessen inter-individual differ-
ences in urine metabolic profiles, equal parts of urine of
each participant were pooled in a sterile 200 ml
Erlenmeyer flask and 65 times 1 ml of urine was aliquoted
to separate 1.5 ml Eppendorf tubes. Five of these aliquots
were immediately frozen at -80 C and used as baseline
reference.
With respect to temperature, we exposed the samples to:
(1) room temperature (*20 C); (2) cool packs (*9 C);
(3) fridge (4 C) and; (4) freezer (-20 C). Additionally,
with respect to the duration, we stored the samples for 2, 8
and 24 h. This resulted in 12 different conditions. As we
prepared four biological replicates, a total of 48 further
aliquots were therefore used (Fig. 1).
Additionally, the influence of freezing and thawing
urine samples was simulated on the remaining 12 aliquots.
Urine was frozen for 24 h at -80 C and thawed for 2 h
at *20 C. This cycle was repeated three times (Fig. 1).
2.2 Targeted metabolite quantification
Each sample was measured with the AbsoluteIDQTM p150
Kit (BIOCRATES Life Sciences AG, Innsbruck, Austria)
and FIA-ESI-MS/MS (flow injection-electrospray ionisa-
tion-triple quadrupol mass spectrometry). The assay pro-
cedures of the AbsoluteIDQTM p150 Kit have been
described in full detail previously (Ro¨misch-Margl et al.
2012). Samples were prepared by a Hamilton Microlab
STARTM robot (Hamilton Bonaduz AG, Bonaduz,
Switzerland) and a Ultravap nitrogen evaporator (Porvair
Sciences, Leatherhead, UK), beside standard laboratory
equipment. Mass spectrometric (MS) analyses were done
on an API 4000 LC–MS/MS System (Sciex Deutschland
GmbH, Darmstadt, Germany) equipped with a 1200 Series
HPLC (Agilent Technologies Deutschland GmbH,
Bo¨blingen, Germany) and a HTC PAL auto sampler (CTC
Analytics, Zwingen, Switzerland) controlled by the soft-
ware Analyst 1.6.1. Data evaluation for quantification of
metabolite concentrations and quality assessment was
performed with the MetIDQTM software package, which is
an integral part of the AbsoluteIDQTM Kit. Metabolite
concentrations [lM] were calculated referring to internal
standards.
Of 10 lL urine, 162 metabolites were quantified. The
baseline reference was measured five times to calculate the
coefficients of variance (CV, Table 1). In the course of
quality control, we excluded metabolites with a CV higher
than 25%. Furthermore, to assure detectability we excluded
metabolites with more than 50% of measured values below
the limit of detection (three times the median value of
water based zero-samples). In total 63 metabolites passed
the quality control: free carnitine, 34 acylcarnitines (Cx:y),
13 proteinogenic amino acids, creatinine, hexoses (sum of
hexoses), 8 glycerophospholipids (7 phosphatidylcholines
(PC) and one lysoPC), and 5 sphingolipids (SM). The
abbreviations Cx:y depicts the total number of carbons and
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double bonds of all chains, respectively (for more details
see the list of metabolites in Table S1).
2.3 Statistical analysis
To account for technical variation due to measurements,
each of the 12 replicates and the three samples that
underwent freeze and thaw cycles was measured four
times. The resulting values were used to calculate the CV
under each condition (Table 1).
All metabolite concentrations were log-transformed and
standardized (mean = 0 and standard deviation = 1). For
each metabolite under each condition, we performed pair-
wise comparisons by applying a Welch-Satterthwaite
Freeze 24h
20°C9°C4°C 2h-20°C 8h
24h-80°C
Baseline
0h
-80°C
20°C
Thaw 2h
3 x 
Fig. 1 Overview of the study design. Urine from six female
volunteers was pooled and aliquoted before being stored at -80,
-20, 4, 9, and 20 C for 0, 2, 8, and 24 h. For freeze and thaw cycles,
samples were frozen for 24 h and thawed for 2 h per cycle. Each
sample was measured four times
Table 1 Significant metabolites identified by the pairwise comparison of baseline concentrations against 24 h at *20 and *9 C
Metabolite Baseline (0 h) 2 h 8 h 24 h
Mean (lM) Change [%) P value CV (%) Change (%) P value CV (%) Change (%) P value CV (%)
*20 C
Arg 17.40 1.0 0.82 5.8 -28.3 0.03 17.9 -40.9 3.1E24 10.8
Met 12.65 -7.1 0.26 5.1 -15.3 0.16 18.0 -43.7 1.3E24 3.5
Ser 248.63 -3.7 0.44 4.8 -17.4 0.05 12.3 -36.2 4.0E25 6.6
Val 30.86 -4.9 0.43 5.8 -21.7 0.09 20.3 -59.0 1.0E25 3.5
xLeu 50.39 -6.1 0.25 3.0 -22.1 0.07 19.4 -39.6 8.8E25 3.6
H1 622.83 3.7 0.19 2.2 -3.0 0.67 15.0 -30.3 9.5E26 4.3
*9 C
C6:1 0.16 1.9 0.77 9.2 2.2 0.76 10.3 16.2 8.1E25 2.6
Arg 17.40 -0.9 0.91 11.0 6.6 0.29 6.3 -40.2 7.2E25 7.0
Val 30.86 -4.9 0.41 4.4 -2.8 0.69 8.8 -42.5 4.8E25 8.1
xLeu 50.39 -2.9 0.64 7.1 0.2 0.96 8.7 -35.3 1.1E24 4.9
The first column shows metabolites with significant changes in their concentration due to storage conditions when compared to the reference
samples that are shown in the second column. The following columns show the percentage of concentration change, the respective P value, and
coefficient variance (CV) derived with from the four measurements of the samples stored at the specified temperatures/conditions (2, 8, and 24 h
at *20 and *9 C). Significant P values (P\ 7.9E-4) are indicated in bold
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separate-variance t test, to assess the differences in
metabolite concentration between samples exposed to 2, 8,
and 24 h at the respective storage condition with baseline
samples (immediately frozen at -80 C). The same t test
was used to pair-wisely compare metabolite concentrations
after the freeze and thaw cycles with baseline. To account
for multiple testing, Bonferroni correction
(P\ 7.9E-4 = 0.05/63) was applied due to 63 used
metabolites.
A mixed effects linear regression model was utilized to
assess the influence of time and temperature, as well as
their interaction term on metabolite concentrations. Addi-
tionally, the variables time and temperature were stan-
dardized (mean = 0 and standard deviation = 1). The
metabolite concentration was used as the dependent vari-
able, time, temperature and their interaction term as the
fixed effect and the repeated measurement as random
effect.
The mixed effects linear regression model was used to
estimate the impact of the number (0–3) of freeze–thaw
cycles on each of the used 63 metabolite concentrations.
Statistical analyses were performed with SAS 9.4 (SAS
Institute, Cary NC) using ‘PROC TTEST’ for pairwise
comparisons of storage conditions and ‘PROC MIXED’ for
the mixed effect linear regression models on the effect of
time, temperature, interaction of time, and temperature and
number of freeze and thaw cycles.
3 Results
3.1 Amino acids are mostly affected by the storage
conditions
We observed that the concentrations of about 90% of
examined metabolites in the urine samples were not sig-
nificantly affected by any of the applied storage conditions
(for 0, 2, 8, and 24 h at -20, 4, *9, and *20 C,
respectively) when compared to samples immediately
stored at -80 C. Only seven out of 63 metabolite con-
centration measurements were significantly altered. The
concentrations of three amino acids were decreased by
35–43% when storing in *9 C, and five by up to about
60% when storing the urine samples at room temperature
for 24 h (Table 1). No significant changes in the concen-
tration of any metabolite could be observed for the storage
at 4 and -20 C, when compared to baseline. Furthermore,
at *20 C, no changes in the concentration of the exam-
ined 63 metabolites could be observed after 2 and 8 h, but
at 24 h Arg, Met, Ser, Val, Leu/Ile, and H1 showed a
significant decrease (Table 1). We observed a significant
decrease for Arg, Val and Leu/Ile and a significant increase
for hexenoylcarnitine (C6:1) at *9 C at 24 h (Fig. 2).
3.2 The interaction of temperature and storage time
is the most important influence
To further investigate the influence of the combination of
time and temperature on the metabolite concentrations, we
applied linear mixed effect models. We observed that the
concentrations of ten metabolites (Arg, Glu, Met, Phe, Pro,
Ser, Thr, Val, Leu/Ile, and H1) showed significant
[P\ 2.6E-4 = 0.05/(63 9 3) to account for three inde-
pendent variables and 63 metabolites] associations with the
interaction term of time and temperature. These ten
metabolites included all that were detected with the pair-
wise comparison of baseline with samples stored
at *20 C for 24 h (Table 2).
3.3 Frequent freeze and thaw cycles influences
the sample quality
To investigate the effect of freeze and thaw cycles, we
conducted pairwise comparisons between samples that
underwent up to three cycles with baseline. We did not
observe any significantly changed metabolite concentration
for one or two freeze and thaw cycles, but two metabolites
(H1 and C3) showed significantly increased concentrations
for three freeze and thaw cycles, when compared to sam-
ples immediately frozen at -80 C (Table 3). Hexose H1
concentrations increased gradually from baseline
(622.83 lM) starting with cycle one (652.28 lM/4.7%)
and two (698.83 lM/12.2%) until 748.95 lM/20.2%
increase after the third cycle (Table S2). Results depicting
the influence of freeze and thaw cycles on all 63 used
metabolites are shown in Table S2.
With the linear mixed effect model, we detected a sig-
nificant association between the number of freeze and thaw
cycles and the concentration of four Acylcarnitines (C3,
C4, C8:1, C16:1-OH) and Hexose (Table 4).
4 Discussion
We investigated the influence of storage conditions (tem-
perature, time and freeze and thaw cycles) on metabolite
profiles in human urine samples using targeted MS and
observed that a full day of storing at room temperature or
on cool packs significantly altered the concentration of
several metabolites, in particular amino acids. This finding
was confirmed by investigating the interaction between
exposure time and temperature. Furthermore, we observed
that more than two freeze and thaw cycles affected the
metabolite concentrations in the urine samples. However,
about 78% of quantified metabolites in urine samples from
overnight fasting females were not influenced by the
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examined storage conditions, when considering a stringent
Bonferroni corrected level of significance.
Although other studies investigated the impact of stor-
age conditions on metabolite profiles in urine as well, they
were using either non-targeted MS or NMR technology
(Table 5). Moreover, none of these studies investigated the
interaction between storage time and temperature, which
previously was only subject to research on the storage of
serum samples (Anton et al. 2015).
Our finding of decreased concentrations of Hexose in
urine at a prolonged exposure to room temperature is
consistent with previous studies in plasma and most likely
results from active glycolysis enzymes in urine (Breier
et al. 2014; Bruns and Knowler 2009; Gro¨tsch et al. 1985).
Furthermore, our observation of decreased concentrations
of arginine and methionine in urine is consistent with
previous observations in plasma at room temperature
(Breier et al. 2014).
The decreased concentrations of the branched chain
amino acids (BCAA, i.e. valine, leucine and isoleucine)
might be explained by the catabolic activity of a multiple
enzyme complex, in particular the branched-chain a-keto
acid dehydrogenase (BCKDC). BCKDC converts all three
amino acid by: (1) transamination; (2) oxidative decar-
boxylation; and (3) dehydrogenation (Tanaka and Rosen-
berg 1983). Indo et al. report BCKDC to be associated with
the mitochondrial inner membrane (Indo et al. 1987).
Prolonged exposure of urine to room temperature might
lead to a degradation of cells and a release of BCKDC. The
reduction in the concentration of these BCAA, when stored
on cool packs is less profound, when compared to room
temperature. The comparably smaller effect is most likely
due to the reduced temperature (Gillim et al. 1983).
Contradictory findings were reported for blood: the
concentrations of leucine, isoleucine and serine in plasma
were found to be increased when stored for 24 h at room
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Fig. 2 Concentrations of two metabolites over time for various
storage conditions. Influence of storage conditions on the concentra-
tions of Valine and C6:1. The concentration of C6:1 at 9 C
increased, whereas the concentration of valine decreased at 20 and
9 C in urine over the course of 24 h
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temperature and for leucine when stored for 24 h on cool
packs (Breier et al. 2014). However this is expected, when
comparing different matrices, such as blood and urine.
Urine at prolonged room temperature is prone to getting
more acidic, whereas blood is buffered (Alguacil et al.
2007). Additionally, the number of cells is not comparable
between the two matrices, which also accounts for the
protein concentration and numerous other factors, such as
bacterial growth. To avoid such interferences by reducing
the number of bacteria and host cells, as well as large
particles, previous studies suggested to pre-centrifuge
(1000–3000 RCF for 5 min at 4 C) and filter urine sam-
ples (using a 0.20 lm filter) before conducting the
metabolite profiling (Bernini et al. 2011; Emwas et al.
2015). However, certain circumstances like the non-avail-
ability of filters and centrifuges and time consuming
operation during real life studies make it difficult to use
said filters directly after donation.
We observed up to 60% reduction of BCAA (isoleucine
and valine) when urine samples are stored on cool packs or
at room temperature for 24 h. These BCAA are in partic-
ular essential for the growth of certain microorganisms,
such as lactobacillus brevis and lactobacillus plantarum
(Katina 2005). L. brevis can be found in intestines, colon
and vagina (Makarova et al. 2006). The interplay of time
and temperature may have led to a consumption and con-
sequent concentration reduction of the respective amino
acids in urine samples.
The detected increase in Hexose (mainly glucose) con-
centration after multiple freeze and thaw cycles might be
due to the reported degeneration of sucrose. The enzyme
invertase, also called sucrase, catalyzes the hydrolysis of
sucrose to glucose and fructose (Huang et al. 1999; Zhang
et al. 2016). Invertase is found in the potential urine con-
taminant yeast (Fisher et al. 1995). Repeated freezing and
thawing might have damaged these cells, led to a diffusion
of invertase in urine and consequently the hydrolysis of
sucrose. Additionally, the acid-catalyzed hydrolysis of
sucrose was reported to be enhanced by freezing (Lund
et al. 1969). Both mechanisms are likely to explain the
gradual increase of glucose concentrations (up to 20%)
after the freeze and thaw cycles.
However, the observation of an opposite trend for the
glucose concentration after freeze and thaw cycles, when
compared to the storing at room temperature for 24 h needs
to be further investigated.
In general, using targeted MS approach we observed
changes in six metabolites (C3, C6:1, Arg, Val, Leu/Iso
Table 2 Metabolites significantly influenced by the interaction of
exposure time and temperature
Metabolite b-estimate (95% CI) P value
Arg -0.89 (-1.26, -0.52) 2.2E25
Gln -0.68 (-0.97, -0.40) 2.5E25
Met -1.00 (-1.31, -0.70) 1.2E27
Phe -0.71 (-1.03, -0.39) 7.8E25
Pro -0.83 (-1.20, -0.46) 5.8E25
Ser -1.01 (-1.26, -0.75) 9.8E210
Thr -0.69 (-1.01, -0.38) 7.7E25
Val -1.01 (-1.44, -0.58) 2.8E25
xLeu -0.95 (-1.28, -0,61) 1.2E26
H1 -1.14 (-1.51, -0.76) 4.5E27
The first column shows metabolites with a significant influence on the
interaction of time and temperature. The following columns show b-
estimates with respective confidence intervals (95%) and P values via
a linear mixed effects model. Significant P values (P\ 2.64E-4) are
indicated in bold
Table 3 Metabolites significantly influenced by freeze and thaw cycles
Metabolite Baseline (0 h) Cycle 1 (26 h) Cycle 2 (52 h) Cycle 3 (78 h)
Mean (lM) Change (%) P value CV (%) Change (%) P value CV (%) Change (%) P value CV (%)
C3 1.00 1.3 0.55 2.3 7.7 0.13 7.1 13.8 7.7E24 1.3
H1 622.84 4.7 0.24 5.6 12.2 0.07 8.3 20.2 3.1E24 3.4
The first column shows metabolites that were significantly changed after the third freeze and thaw cycle when compared to the baseline values
that are shown in the second column. The following columns show the percentage of concentration change, the respective P value, and
coefficient variance (CV) derived with from the measurements of the sample after one, two, and three freeze and thaw cycles. Significant
P values (P\ 7.9E-4) are indicated in bold
Table 4 Metabolites significantly associated with the number of
freeze and thaw cycles
Metabolite b-estimate (95% CI) P value
C3 0.53 (0.41–1.03) 2.5E24
C4 0.62 (0.36–0.88) 1.8E24
C8:1 0.70 (0.39–1.01) 2.9E24
C16:1-OH 0.72 (0.41–1.03) 2.5E24
H1 0.45 (0.27–0.64) 1.5E24
The first column shows metabolites that were significantly associated
with the number of freeze and thaw cycles. The following columns
show b-estimates with respective confidence intervals (95%) and
P values derive with a linear mixed effects model. Significant P val-
ues (P\ 7.9E-4) are indicated in bold
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(xLeu), H1) that were not reported in other studies that
applied similar storage conditions (e.g. 24 h at 10 C, up to
nine freeze and thaw cycles), but different measurement
techniques (NMR, non-targeted MS) (Budde et al. 2016;
Gika et al. 2008). Other observed alterations in the
metabolite profiles were derived under conditions that were
not part of our study (e.g. 72 h or 12 weeks at 4 C) (Lau-
ridsen et al. 2007; Roux et al. 2015). Due to the comparably
small number of measurements, our study is limited in sta-
tistical power. Additionally, the AbsoluteIDQTM p150 kit
was originally developed for blood samples, and not focus-
ing on urine. This is reflected by the number of only 63
metabolites that passed the quality control. In order to make
the kit more applicable to urine, creatinine was included by
the manufacturer into the metabolite panel, to enable
researchers to account and normalize for different urine
excretion rates. Furthermore, the measured values were not
derived from biological replicates, but from repeated mea-
surements of the same samples. However, by this procedure,
potential analytical variations could be identified and
accounted for. Furthermore, by using pooled samples, we do
not have to account for different excretion rates and differ-
ences in interpersonal metabolite profiles. This supports the
direct comparability of measured effects.
5 Conclusions
The findings from our study suggested to avoid shipping
urine samples on cool packs or at room temperature for
durations of more than 8 h, and we have provided insight
on improved planning and sample maintenance in the field.
We strongly recommend storage temperatures of at least
-20 C and to minimize the number of freeze and thaw
cycles to ensure integrity of urine samples used for meta-
bolomics studies.
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Table 5 Previous studies on pre-analytical sample handling
Author Technique Approach Tissue Temperature Time Interaction Freeze/
thaw cycles
Lauridsen
et al. (2007)
NMR Non-
targeted
Urine -80, -25, and 4 C 0, 1, 2, 3, 4, 6, 10, 14, and
26 weeks
– –
Barton et al.
(2008)
NMR Non-
targeted
Urine, serum -80 and 4 C 0, 24, and 36 h – –
Bernini et al.
(2011)
NMR Non-
targeted
Urine, serum
plasma
-80, 4 C, and RT 0, 2, 4, 6, 24 h, and 1 week – –
Roux et al.
(2015)
NMR, MS Non-
targeted
Urine -80, 4 C, and RT
(19–26 C)
0–72 h (every 4 or 12 h) – –
Budde et al.
(2016)
NMR Non-
targeted
Urine -80, 4, 10 C, and RT
(25 C)
0, 1, 2, 8, 10, 12, 24, 28,
72 h, and 1 month
– –
Gika et al.
(2008)
MS Non-
targeted
Urine -80, -20, and -4 C, 1 week, 1 month,
3 months, and 6 months
– X (-20 C)
Breier et al.
(2014)
MS Targeted Serum,
plasma
-80, *4 C, and RT
(21 C)
0, 3, 6, and 24 h – X (-20 C)
Anton et al.
(2015)
MS Targeted Serum -80 C, dry ice, wet ice,
and RT (22–24 C)
0, 12, 24, and 36 h X X (-80 C)
Rotter et al. MS Targeted Urine -80, -20, 4, *9 C, and
RT (*20 C)
0, 2, 8, and 24 h X X (-80 C)
The first three columns indicate the underlying study and the technical approach that was applied. The following columns depict the examined
tissue and the pre-processing conditions (temperature, time, and their interaction), the samples were exposed to. The final column indicates if
freeze and thaw cycles were subject to the respective study
RT room temperature, NMR nuclear magnetic resonance, MS mass spectrometry
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